Clinical Trial: PRECISION MEDICINE APPLIED TO THE STUDY OF ENDOMETRIAL CANCER: APPLICATION OF NGS FOR MOLECULAR CLASSIFICATION.

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07006103) titled 'PRECISION MEDICINE APPLIED TO THE STUDY OF ENDOMETRIAL CANCER: APPLICATION OF NGS FOR MOLECULAR CLASSIFICATION.' on May 16.

Brief Summary: In recent years, knowledge about cancer biology has expanded significantly. The study of gene expression profiles has revealed the heterogeneous nature and potential reclassification of the various tumor subtypes based on specific genetic alterations. This is of great importance since it allows a therapeutic approach more directed to the intrinsic characteristics of each tumor (precision medicine).

Integrating clinicopathological information with molecular classification could provide new guideli...